The global Veterinary Pharmacovigilance market size in 2022 is 680.2 million US dollars, and it is expected to be 1600.0 million US dollars by 2029, with a compound annual growth rate of 13.10% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Veterinary Pharmacovigilance market include Accenture PLC, ArisGlobal LLC, Ennov SAS, Sarjen Systems Pvt. Ltd., and PharSafer Associates Ltd.. The share of the top 3 players in the Veterinary Pharmacovigilance market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Veterinary Pharmacovigilance market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Anti-infectives accounted for XX% of Veterinary Pharmacovigilance market in 2022. Biologics share of XX%.
Dogs accounted for XX% of the Veterinary Pharmacovigilance market in 2022. Cats accounts for XX%.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Veterinary Pharmacovigilance Market dynamics, structure by identifying and analyzing the market segments and project the global market size.
In addition, the market SWOT analysis, dynamics, trends, technologies, opportunities and challenges analysis are covered in the report.
Further, the report also focuses on the competitive analysis of key players by product, financial position, product portfolio, growth strategies, and regional presence.
?
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Highlights-Regions
North America
United States
Canada
China
Asia Pacific (Excluding China)
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Nordic
Latin America
Brazil
Argentina
Mexico
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Player list
Accenture PLC
ArisGlobal LLC
Ennov SAS
Sarjen Systems Pvt. Ltd.
PharSafer Associates Ltd.
Knoell Germany GmbH
biologit
Indivirtus Group (Indivirtus Healthcare Services)
Oy Medfiles Ltd.
Azierta Life Sciences & Health Consulting Firm S.L
Types list
Anti-infectives
Biologics
Others
Application list
Dogs
Cats
Others
